Non-progressing patients with ILE tend to have absence of severe organ involvement and have a relatively simple serologic profile. products have been identified as markers with positive predictive value, particularly when combined together. Once this patient population is better characterized biochemically, clinical trials should be considered with the primary objective to completely halt or slow … Continue reading Non-progressing patients with ILE tend to have absence of severe organ involvement and have a relatively simple serologic profile